These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3927286)

  • 61. Characterization of the backbone dynamics of an anti-digoxin antibody VL domain by inverse detected 1H-15N NMR: comparisons with X-ray data for the Fab.
    Constantine KL; Friedrichs MS; Goldfarb V; Jeffrey PD; Sheriff S; Mueller L
    Proteins; 1993 Mar; 15(3):290-311. PubMed ID: 8456098
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improvement of heavy and light chain assembly by modification of heavy chain constant region 1 (CH1): Application for the construction of an anti-paclitaxel fragment antigen-binding (Fab) antibody.
    Yusakul G; Sakamoto S; Tanaka H; Morimoto S
    J Biotechnol; 2018 Dec; 288():41-47. PubMed ID: 30389640
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain.
    Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP
    Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cloning and characterization of cDNAs encoding VH and VL of a monoclonal anti-CEA antibody (CEA 79) cross-reactive with NCA-95 and generation of a single-chain Fv molecule (scFv).
    Chung JH; Choi SJ; Kim HJ; Kim IJ; Choi IH; Lee SD; Yi KS; Suh PG; Ryu SH; Chung HK
    Mol Cells; 1997 Dec; 7(6):816-9. PubMed ID: 9509426
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The invariant system of coordinates of antibody molecules: prediction of the "standard" C alpha framework of VL and VH domains.
    Gelfand IM; Kister AE; Leshchiner D
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3675-8. PubMed ID: 8622995
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface.
    Vranken W; Tolkatchev D; Xu P; Tanha J; Chen Z; Narang S; Ni F
    Biochemistry; 2002 Jul; 41(27):8570-9. PubMed ID: 12093273
    [TBL] [Abstract][Full Text] [Related]  

  • 67. VL-VH expression by monoclonal antibodies recognizing avian lysozyme.
    Smith-Gill SJ; Mainhart CR; Lavoie TB; Rudikoff S; Potter M
    J Immunol; 1984 Feb; 132(2):963-7. PubMed ID: 6418816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can intrabodies targeted to the secretory compartment interact with a cytosolic protein? A comment on the article by Sawahata et al. "Cytoplasmic expression and specific binding of the VH/VL single domain intrabodies in transfected NIH3T3 cells", Exp. Mol. Pathol. 2008 Nov 27; Epub ahead of print.
    Cardinale A; Biocca S
    Exp Mol Pathol; 2009 Apr; 86(2):138. PubMed ID: 19348064
    [No Abstract]   [Full Text] [Related]  

  • 69. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
    Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
    J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Different VL and VH germ-line genes are used to produce similar combining sites with specificity for alpha(1----6)dextrans.
    Akolkar PN; Sikder SK; Bhattacharya SB; Liao J; Gruezo F; Morrison SL; Kabat EA
    J Immunol; 1987 Jun; 138(12):4472-9. PubMed ID: 2438345
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Contributions of immunoglobulin heavy and light chains to antibody specificity for lysozyme and two haptens.
    Smith-Gill SJ; Hamel PA; Lovoie TB; Dorrington KJ
    J Immunol; 1987 Dec; 139(12):4135-44. PubMed ID: 2447160
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.
    Derrick JP; Maiden MC; Feavers IM
    J Mol Biol; 1999 Oct; 293(1):81-91. PubMed ID: 10512717
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure.
    Chothia C; Lesk AM; Levitt M; Amit AG; Mariuzza RA; Phillips SE; Poljak RJ
    Science; 1986 Aug; 233(4765):755-8. PubMed ID: 3090684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies.
    Atwell JL; Breheney KA; Lawrence LJ; McCoy AJ; Kortt AA; Hudson PJ
    Protein Eng; 1999 Jul; 12(7):597-604. PubMed ID: 10436086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Monoclonal anti-H1 histone autoantibodies from unimmunized Balb/c mice. Specificity and VH and VL domain sequences.
    Underwood JR; Cartwright GA; McCall AM; Tribbick G; Geysen MH; Hearn MT
    J Autoimmun; 1994 Jun; 7(3):291-320. PubMed ID: 7916905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recombinant thyroid peroxidase-specific autoantibodies. II. Role of individual heavy and light chains in determining epitope recognition.
    Costante G; Portolano S; Nishikawa T; Jaume JC; Chazenbalk GD; Rapoport B; McLachlan SM
    Endocrinology; 1994 Jul; 135(1):25-30. PubMed ID: 7516865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An unusual human IgM antibody with a protruding HCDR3 and high avidity for its peptide ligands.
    Ramsland PA; Shan L; Moomaw CR; Slaughter CA; Fan Z; Guddat LW; Edmundson AB
    Mol Immunol; 2000 Apr; 37(6):295-310. PubMed ID: 11000403
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Kinetic analysis of the interactions of recombinant human VpreB and Ig V domains.
    Hirabayashi Y; Lecerf JM; Dong Z; Stollar BD
    J Immunol; 1995 Aug; 155(3):1218-28. PubMed ID: 7636190
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
    Jäger M; Plückthun A
    J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.